Patents by Inventor ERIC J. SNIJDER

ERIC J. SNIJDER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY
    Publication number: 20190201352
    Abstract: The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting several coronaviruses.
    Type: Application
    Filed: March 12, 2019
    Publication date: July 4, 2019
    Inventors: KATHERINE L. RADTKE, HANNAH PETERS, JOHAN NEYTS, DIRK JOCHMANS, ERIC J. SNIJDER
  • Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
    Patent number: 10226434
    Abstract: The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting several coronaviruses.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: March 12, 2019
    Assignees: University of Maryland, Baltimore County, Katholieke Universiteit Leuven/Lieden University Medical Center, RC Leiden
    Inventors: Katherine L. Radtke, Hannah Peters, Johan Neyts, Dirk Jochmans, Eric J. Snijder
  • DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY
    Publication number: 20180303768
    Abstract: The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting several coronaviruses.
    Type: Application
    Filed: July 2, 2018
    Publication date: October 25, 2018
    Inventors: KATHERINE L. RADTKE, HANNAH PETERS, JOHAN NEYTS, DIRK JOCHMANS, ERIC J. SNIJDER
  • Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
    Patent number: 10058516
    Abstract: The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting several coronaviruses.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: August 28, 2018
    Assignees: University of Maryland Baltimore County, Katholieke Universiteit Leuven, Leiden University Medical Center
    Inventors: Katherine L. Radtke, Hannah L. Peters, Johan Neyts, Dirk Jochmans, Eric J. Snijder
  • DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY
    Publication number: 20180015052
    Abstract: The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting several coronaviruses.
    Type: Application
    Filed: January 28, 2016
    Publication date: January 18, 2018
    Inventors: KATHERINE L. RADTKE, HANNAH L. PETERS, JOHAN NEYTS, DIRK JOCHMANS, ERIC J. SNIJDER